JP2013515006A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515006A5 JP2013515006A5 JP2012544924A JP2012544924A JP2013515006A5 JP 2013515006 A5 JP2013515006 A5 JP 2013515006A5 JP 2012544924 A JP2012544924 A JP 2012544924A JP 2012544924 A JP2012544924 A JP 2012544924A JP 2013515006 A5 JP2013515006 A5 JP 2013515006A5
- Authority
- JP
- Japan
- Prior art keywords
- dca
- synthetic
- pharmaceutical composition
- weight
- total amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XXVDSHGQWYNBEP-SQVHVIJFSA-N C[C@H](CCC(O)=O)[C@@H](CC[C@H]1[C@H](CC2)[C@H](C3)[C@@](C)(CC4)[C@@]2(C)C[C@@H]4O)[C@@]1(C)[C@H]3O Chemical compound C[C@H](CCC(O)=O)[C@@H](CC[C@H]1[C@H](CC2)[C@H](C3)[C@@](C)(CC4)[C@@]2(C)C[C@@H]4O)[C@@]1(C)[C@H]3O XXVDSHGQWYNBEP-SQVHVIJFSA-N 0.000 description 3
- 0 C[C@](CC*)[C@@](CC[C@]1[C@](CC2)[C@@](C3)[C@@](C)(CC4)[C@@]2C[C@@]4O)[C@@]1(C)[C@@]3O Chemical compound C[C@](CC*)[C@@](CC[C@]1[C@](CC2)[C@@](C3)[C@@](C)(CC4)[C@@]2C[C@@]4O)[C@@]1(C)[C@@]3O 0.000 description 2
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28813209P | 2009-12-18 | 2009-12-18 | |
| US61/288,132 | 2009-12-18 | ||
| US30200710P | 2010-02-05 | 2010-02-05 | |
| US61/302,007 | 2010-02-05 | ||
| US30381610P | 2010-02-12 | 2010-02-12 | |
| US61/303,816 | 2010-02-12 | ||
| GB1008726.0 | 2010-05-25 | ||
| GB1008726A GB2480632A (en) | 2010-05-25 | 2010-05-25 | Preparation of 12-keto and 12-alpha-hydroxy steroids |
| US34868610P | 2010-05-26 | 2010-05-26 | |
| US61/348,686 | 2010-05-26 | ||
| PCT/US2010/061150 WO2011075701A2 (en) | 2009-12-18 | 2010-12-17 | Methods for the purification of deoxycholic acid |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016161932A Division JP6568025B2 (ja) | 2009-12-18 | 2016-08-22 | デオキシコール酸の合成および精製のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515006A JP2013515006A (ja) | 2013-05-02 |
| JP2013515006A5 true JP2013515006A5 (enExample) | 2018-03-22 |
| JP6393023B2 JP6393023B2 (ja) | 2018-09-19 |
Family
ID=42341289
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012544924A Expired - Fee Related JP6393023B2 (ja) | 2009-12-18 | 2010-12-17 | デオキシコール酸の調製のための方法 |
| JP2016161932A Expired - Fee Related JP6568025B2 (ja) | 2009-12-18 | 2016-08-22 | デオキシコール酸の合成および精製のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016161932A Expired - Fee Related JP6568025B2 (ja) | 2009-12-18 | 2016-08-22 | デオキシコール酸の合成および精製のための方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US20130137884A1 (enExample) |
| EP (2) | EP2513132B9 (enExample) |
| JP (2) | JP6393023B2 (enExample) |
| KR (3) | KR102058420B1 (enExample) |
| CN (3) | CN102812035A (enExample) |
| AU (1) | AU2010330760B2 (enExample) |
| CA (1) | CA2782478A1 (enExample) |
| EA (2) | EA031768B1 (enExample) |
| ES (1) | ES2575559T3 (enExample) |
| GB (1) | GB2480632A (enExample) |
| IL (2) | IL220225A0 (enExample) |
| MY (1) | MY167891A (enExample) |
| NZ (1) | NZ700195A (enExample) |
| PH (1) | PH12012501233A1 (enExample) |
| SG (3) | SG10201509046TA (enExample) |
| WO (1) | WO2011075701A2 (enExample) |
| ZA (1) | ZA201204388B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
| US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
| GB2480632A (en) | 2010-05-25 | 2011-11-30 | Kythera Biopharmaceuticals Inc | Preparation of 12-keto and 12-alpha-hydroxy steroids |
| MX363465B (es) | 2011-02-18 | 2019-03-25 | Kythera Biopharmaceuticals Inc | Tratamiento de la grasa submental. |
| US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
| TWI572616B (zh) * | 2011-06-16 | 2017-03-01 | 凱瑟拉生物製藥有限公司 | 去氧膽酸之組成物及用途及其相關方法 |
| US20130102580A1 (en) * | 2011-09-22 | 2013-04-25 | Kythera Biopharmaceuticals, Inc. | Compositions and methods related to deoxycholic acid and its polymorphs |
| WO2013044119A1 (en) * | 2011-09-22 | 2013-03-28 | Kythera Biopharmaceuticals, Inc. | Compositions and methods related to deoxycholic acid and its polymorphs |
| CN104447929B (zh) * | 2014-10-28 | 2016-06-29 | 湖南科瑞生物制药股份有限公司 | 一种合成3-羰基-4-雄烯-17β羧酸的方法 |
| CN106146593B (zh) * | 2015-04-14 | 2021-06-01 | 南京迈诺威医药科技有限公司 | 一种制备去氧胆酸的方法 |
| CN106046093A (zh) * | 2016-05-30 | 2016-10-26 | 华东师范大学 | 一种石胆酸的合成方法 |
| JP7050008B2 (ja) * | 2016-06-06 | 2022-04-07 | クリスタル ファーマ，エセ．ア．ウ． | デオキシコール酸の調製方法、およびデオキシコール酸の調製に有用な中間体 |
| EP3511006B1 (en) * | 2016-08-11 | 2021-08-04 | Samsung Life Public Welfare Foundation | Composition for preventing, improving or treating hair loss comprising deoxycholic acid as active ingredient |
| EP3645548B1 (en) | 2017-08-03 | 2023-11-29 | Medytox Inc. | Methods for preparing bile acids |
| JP6899529B2 (ja) | 2017-08-10 | 2021-07-07 | パナソニックＩｐマネジメント株式会社 | 冷凍サイクル用作動媒体および冷凍サイクルシステム |
| CN114478676B (zh) * | 2022-02-18 | 2024-05-10 | 国药集团化学试剂有限公司 | 一种脱氧胆酸钠的制备方法 |
| CN116444597B (zh) * | 2023-03-30 | 2025-03-28 | 南京迈诺威医药科技有限公司 | 一种制备去氧胆酸中间体和去氧胆酸的方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US53446A (en) | 1866-03-27 | Improvement in cultivators | ||
| US2321598A (en) | 1940-10-07 | 1943-06-15 | George A Breon & Company Inc | Preparation of desoxycholic acid |
| US2509248A (en) * | 1947-09-05 | 1950-05-30 | Merck & Co Inc | Process for producing delta9, 11-3(alpha)-hydroxy-17-ketoetiocholene |
| GB695504A (en) | 1950-10-18 | 1953-08-12 | Drug Res Inc | Method of isolating and purifying cholic and desoxycholic acids |
| GB716670A (en) | 1951-06-19 | 1954-10-13 | Armour & Co | Improved process for purifying desoxycholic acid from contaminating cholic acid |
| US2651643A (en) * | 1951-06-19 | 1953-09-08 | Armour & Co | Purification of desoxycholic acid |
| US2891972A (en) | 1952-08-19 | 1959-06-23 | Drug Res Inc | Process of separating desoxycholic acid from mixed crude bile acids or salts thereof |
| US3533908A (en) | 1967-05-19 | 1970-10-13 | Brown Co | Porous paperboard sheet having plastic microspheres therein |
| IT1202370B (it) | 1976-07-12 | 1989-02-09 | Hoffmann La Roche | Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti |
| FR2446293A1 (fr) | 1978-12-11 | 1980-08-08 | Roussel Uclaf | Procede de purification de l'acide chenodesoxycholique |
| IT8167097A0 (it) | 1981-01-26 | 1981-01-26 | Unilever Nv | Composizione cosmetica per il trattamento della pelle o dei capelli |
| ES2033516T3 (es) | 1988-04-08 | 1993-03-16 | Roussel-Uclaf | Procedimiento para preparar 9 alfa-hidroxi-17 metileno-esteroides. |
| US5085864A (en) | 1989-10-30 | 1992-02-04 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
| CA2033725C (en) | 1990-01-24 | 2001-05-29 | Folker Pittrof | Pharmaceutical and cosmetic compositions containing a salt of cholanic acid |
| ATE324897T1 (de) | 1994-07-25 | 2006-06-15 | Nda Int Inc | Verwendung von noribogain derivaten zur behandlung von chemischer abhängigkeit bei säugern |
| US20020107291A1 (en) | 1997-05-26 | 2002-08-08 | Vincenzo De Tommaso | Clear, injectable formulation of an anesthetic compound |
| IL123998A (en) | 1998-04-08 | 2004-09-27 | Galmed Int Ltd | Conjugates of bile salts and pharmaceutical preparations containing them |
| US6417179B1 (en) | 1998-10-13 | 2002-07-09 | Craig G. Burkhart | Ear wax solution |
| JP2002536415A (ja) * | 1999-02-12 | 2002-10-29 | セルパス インコーポレイテッド | 抗腫瘍療法 |
| EP1255566A2 (en) | 2000-02-04 | 2002-11-13 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
| EP1404700A2 (en) * | 2001-05-22 | 2004-04-07 | Inflazyme Pharmaceuticals, Ltd. | Process for the production of 6,7-dihydroxy steroid compounds by allylic oxidation of steroid-5-ene compounds to steroid-5-ene-7-one compounds followed by hydroboration and oxidation and intermediates of this process |
| MXPA06013437A (es) | 2004-05-19 | 2007-03-23 | Los Angeles Biomed Res Inst | Uso de un detergente para la eliminacion no quirurgica de grasa. |
| US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
| US7754230B2 (en) | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
| US20060222695A1 (en) | 2005-04-01 | 2006-10-05 | Filiberto Zadini | Deoxycholic acid liposome-based dermatological topical preparation |
| CN101148468A (zh) | 2006-09-19 | 2008-03-26 | 天津科技大学 | 以动物胆汁为原料高效提取胆红素和胆汁酸技术 |
| AU2008209566C1 (en) * | 2007-01-19 | 2013-02-14 | Intercept Pharmaceuticals, Inc. | 23-substituted bile acids as TGR5 modulators and methods of use thereof |
| US20080318870A1 (en) | 2007-06-19 | 2008-12-25 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
| JOP20180077A1 (ar) * | 2007-06-19 | 2019-01-30 | Kythera Biopharmaceuticals Inc | تركيبات وطرق لحمض صفراوي تخليقي |
| KR101916024B1 (ko) * | 2007-06-19 | 2018-11-08 | 키쎄라 바이오파마슈티컬즈 인코포레이티드 | 합성 담즙산 조성물, 방법 및 제조물 |
| HUE028327T2 (en) * | 2008-06-06 | 2017-02-28 | Neurmedix Inc | A process for the preparation of 17-alkynyl-7-hydroxy steroids and related compounds |
| GB2480632A (en) | 2010-05-25 | 2011-11-30 | Kythera Biopharmaceuticals Inc | Preparation of 12-keto and 12-alpha-hydroxy steroids |
| TWI572616B (zh) | 2011-06-16 | 2017-03-01 | 凱瑟拉生物製藥有限公司 | 去氧膽酸之組成物及用途及其相關方法 |
| US20130102580A1 (en) | 2011-09-22 | 2013-04-25 | Kythera Biopharmaceuticals, Inc. | Compositions and methods related to deoxycholic acid and its polymorphs |
-
2010
- 2010-05-25 GB GB1008726A patent/GB2480632A/en not_active Withdrawn
- 2010-12-17 CN CN2010800567638A patent/CN102812035A/zh active Pending
- 2010-12-17 SG SG10201509046TA patent/SG10201509046TA/en unknown
- 2010-12-17 SG SG2012044665A patent/SG181768A1/en unknown
- 2010-12-17 US US13/140,421 patent/US20130137884A1/en not_active Abandoned
- 2010-12-17 KR KR1020187014486A patent/KR102058420B1/ko not_active Expired - Fee Related
- 2010-12-17 EA EA201290334A patent/EA031768B1/ru not_active IP Right Cessation
- 2010-12-17 EP EP10798913.9A patent/EP2513132B9/en not_active Not-in-force
- 2010-12-17 PH PH1/2012/501233A patent/PH12012501233A1/en unknown
- 2010-12-17 CN CN201710119352.2A patent/CN106955287A/zh active Pending
- 2010-12-17 EA EA201791511A patent/EA035380B1/ru not_active IP Right Cessation
- 2010-12-17 EP EP15202046.7A patent/EP3040342A1/en not_active Withdrawn
- 2010-12-17 AU AU2010330760A patent/AU2010330760B2/en not_active Ceased
- 2010-12-17 MY MYPI2012002415A patent/MY167891A/en unknown
- 2010-12-17 ES ES10798913.9T patent/ES2575559T3/es active Active
- 2010-12-17 WO PCT/US2010/061150 patent/WO2011075701A2/en not_active Ceased
- 2010-12-17 JP JP2012544924A patent/JP6393023B2/ja not_active Expired - Fee Related
- 2010-12-17 SG SG10201803507YA patent/SG10201803507YA/en unknown
- 2010-12-17 KR KR1020127017236A patent/KR101787719B1/ko not_active Expired - Fee Related
- 2010-12-17 CA CA2782478A patent/CA2782478A1/en not_active Abandoned
- 2010-12-17 KR KR1020177011484A patent/KR101862599B1/ko not_active Expired - Fee Related
- 2010-12-17 CN CN201710119383.8A patent/CN107011401A/zh active Pending
-
2012
- 2012-06-07 IL IL220225A patent/IL220225A0/en unknown
- 2012-06-14 ZA ZA2012/04388A patent/ZA201204388B/en unknown
-
2014
- 2014-09-19 NZ NZ700195A patent/NZ700195A/en not_active IP Right Cessation
- 2014-11-04 US US14/532,940 patent/US9683007B2/en active Active
-
2016
- 2016-08-22 JP JP2016161932A patent/JP6568025B2/ja not_active Expired - Fee Related
-
2017
- 2017-05-23 US US15/603,290 patent/US10005813B2/en active Active
-
2018
- 2018-05-25 US US15/990,135 patent/US10472384B2/en active Active
- 2018-09-02 IL IL261526A patent/IL261526A/en unknown
-
2019
- 2019-10-02 US US16/591,539 patent/US10981946B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515006A5 (enExample) | ||
| JP2011518833A5 (enExample) | ||
| JP2013515822A5 (enExample) | ||
| JP2011207901A5 (enExample) | ||
| JP2011105738A5 (enExample) | ||
| JP2009149903A5 (enExample) | ||
| JP2007327074A5 (enExample) | ||
| JP2010530373A5 (enExample) | ||
| JP2014221842A5 (enExample) | ||
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| JP2017514910A5 (enExample) | ||
| WO2011146583A3 (en) | Nanoparticulate cinacalcet formulations | |
| JP2013510216A5 (enExample) | ||
| WO2011089126A3 (en) | Novel retigabine composition | |
| JP2013532130A5 (enExample) | ||
| AR077203A1 (es) | Forma polimorfica d del acetato de bazedoxifeno, composiciones farmaceuticas que la contienen metodo para prepararla y uso del mismo para tratar enfermedades mediadas por moduladores selectivos de receptores estrogenicos (serms) | |
| JP2014235432A5 (enExample) | ||
| CN103717571B8 (zh) | 9‑氨基甲基取代的四环素类化合物 | |
| NZ600263A (en) | 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof | |
| JP2010508310A5 (enExample) | ||
| JP2014528494A5 (enExample) | ||
| BR112014029734A2 (pt) | materiais comestíveis e fabricação dos mesmos | |
| JP2010209099A5 (enExample) | ||
| JP2014522395A5 (enExample) | ||
| HK1217333A1 (zh) | 喹唑啉衍生物的固態形式及其作爲braf抑制劑的用途 |